Form 4 for MRVL Marvell Technology
Accepted 2025-04-17 00:00:00 ET · period of report 2025-04-15 · accession 0001835632-25-000084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-17 | 2025-04-15 | MRVL | MURPHY MATTHEW J | COB, CEO, Dir | F - Tax | $53.32 | -8,195 | 241.6K | -3% | -$437.0K |
| DM | 2025-04-17 | 2025-04-15 | MRVL | MURPHY MATTHEW J | COB, CEO, Dir | M - OptEx | $0.00 | +15.6K | 244.5K | +7% | $0 |
| DM | 2025-04-17 | 2025-04-15 | MRVL | MURPHY MATTHEW J | COB, CEO, Dir | M - OptEx | $0.00 | -15.6K | 55.8K | -22% | $0 |
| D | 2025-04-17 | 2025-04-15 | MRVL | MURPHY MATTHEW J | COB, CEO, Dir | A - Grant | $0.00 | +100.9K | 100.9K | New | $0 |
| D | 2025-04-17 | 2025-04-15 | MRVL | MURPHY MATTHEW J | COB, CEO, Dir | J - Other | $0.00 | -144.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-15 | F | D | 3,669 | $53.32 | 244,911 | D | — | — | |
| 2 | Common | Common Stock | 2025-04-15 | M | A | 3,075 | $0.00 | 240,618 | D | — | — | |
| 3 | Common | Common Stock | 2025-04-15 | F | D | 1,619 | $53.32 | 238,999 | D | — | — | |
| 4 | Common | Common Stock | 2025-04-15 | M | A | 6,968 | $0.00 | 248,580 | D | — | — | |
| 5 | Common | Common Stock | 2025-04-15 | F | D | 2,907 | $53.32 | 241,612 | D | — | — | |
| 6 | Common | Common Stock | 2025-04-15 | M | A | 5,520 | $0.00 | 244,519 | D | — | — | |
| 7 | Derivative | Restricted Stock Units | 2025-04-15 | M | D | 3,075 | $0.00 | 0 | D | — · — to — | 3,075 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F3) This grant fully vested on 04/15/2025. |
| 8 | Derivative | Restricted Stock Units | 2025-04-15 | M | D | 5,520 | $0.00 | 33,115 | D | — · — to — | 5,520 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F4) The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026 and 04/15/2026. |
| 9 | Derivative | Restricted Stock Units | 2025-04-15 | A | A | 100,904 | $0.00 | 100,904 | D | — · — to — | 100,904 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F7) The RSUs will vest in equal quarterly installments over three years, and were granted as part of the annual grant process. |
| 10 | Derivative | Restricted Stock Units | 2025-04-15 | J | D | 144,662 | $0.00 | 0 | D | — · — to — | 144,662 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F6) This grant fully vested on 04/15/2025, but settlement of this grant has been deferred by the recipient. Reflects the number of shares earned in respect of performance based restricted stock units granted on 04/15/2022. The achievement levels of the relative TSR performance metrics applicable to the award and the number of shares earned based on such results that were certified on 04/15/2025. |
| 11 | Derivative | Restricted Stock Units | 2025-04-15 | M | D | 6,968 | $0.00 | 55,750 | D | — · — to — | 6,968 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell common share upon vesting. (F5) The remaining RSUs will vest on 07/15/2025, 10/15/2025, 01/15/2026, 04/15/2026, 07/15/2026, 10/15/2026, 01/15/2027, and 04/15/2027. |